BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8958933)

  • 1. Regulation of experimental autoimmune encephalomyelitis by interleukin-12.
    Leonard JP; Waldburger KE; Goldman SJ
    Ann N Y Acad Sci; 1996 Oct; 795():216-26. PubMed ID: 8958933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms.
    Waldburger KE; Hastings RC; Schaub RG; Goldman SJ; Leonard JP
    Am J Pathol; 1996 Feb; 148(2):375-82. PubMed ID: 8579100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.
    Leonard JP; Waldburger KE; Goldman SJ
    J Exp Med; 1995 Jan; 181(1):381-6. PubMed ID: 7528773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
    Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
    J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
    Peng Y; Liu CP
    Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
    Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
    J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
    Mohindru M; Kang B; Kim BS
    J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
    J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood.
    Hofstetter HH; Kovalovsky A; Shive CL; Lehmann PV; Forsthuber TG
    J Neuroimmunol; 2007 Jul; 187(1-2):20-30. PubMed ID: 17482277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
    J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
    Xu H; Rizzo LV; Silver PB; Caspi RR
    Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.